EGFR and non-small cell lung carcinoma: Mutations have been discovered in several genes in addition to EGFR that are involved in the pathogenesis of NSCLC (i.e. KRAS, NRAS, HER2, AKT1, BRAF, PIC3CA) and the demand for multiplex analysis of these genes is increasing.